When to stop fertility treatment: expert insights on IVF prognosis, emotional health, donor options, adoption, grief, and family-building choices.
ASRM’s Fertility and Sterility series examines restorative reproductive medicine, IVF alternatives, and evidence-based fertility care amid growing policy debate.
ASRM updates recurrent pregnancy loss guidance with evidence-based evaluation, targeted care, and emotional support during High-Risk Pregnancy Week.
ASRM responds to Trump IVF insurance proposal, urging broader fertility care access and public input on draft coverage rules.
Since 1989, National Infertility Awareness Week (NIAW) has marked a critical moment each April to elevate public understanding of infertility and push for better care.
Federal funding cuts to NIH, CDC, and FDA threaten reproductive health research, patient safety, and access to care, warns new ASRM policy report.
Study finds PFAS “forever chemicals” may harm fertility, raise preeclampsia risk, and increase preterm birth, highlighting urgent reproductive health concerns.
The Impact of Federal Funding Cuts on Patients, Providers, and the Field of Reproductive Medicine.
Uterine fibroids are benign (noncancerous) tumors of muscle tissue in the uterus. They are also called myomas or leiomyomas.
The menopausal transition (perimenopause) is the period that links a woman’s reproductive (childbearing) years and menopause.
Displaying 291 to 300 of 431 records
